Scientific work

Prof. Dr. Fikret Arpacı

737 publications. The source of the information is stated next to each publication.

Back to profile
  1. HA KARGI, Ö Sagol, S Özuysal

    Source: livhospital.com profile page

  2. Turkish Journal of Cancer 27 (1), 13-18

    Source: livhospital.com profile page

  3. A Özet, G Özet, Z Çalişkaner, Ş Kömürcü, F Arpaci, Ö Berk

    Source: livhospital.com profile page

  4. Oncology 54 (6), 516-516

    Source: livhospital.com profile page

  5. Turkiye Klinikleri Journal of Medical Sciences 11 (4), 264-271

    Source: livhospital.com profile page

  6. Tıbbi Onkolojide Temel İlkeler

    Source: livhospital.com profile page

  7. Turkiye Klinikleri Radiology-Special Topics 15 (2), 1-6

    Source: livhospital.com profile page

  8. Colorectal Cancer in Patients Aged [less than or equal to] 30 Years: 17 Years of Experience

    Source: livhospital.com profile page

  9. S Ozaydin, A Erman, M Tannseven, MA Kaplan, P Hartendorp, A Unlu, ...

    Source: livhospital.com profile page

  10. Erciyes Medical Journal 41 (1), 62-69

    Source: livhospital.com profile page

  11. Journal of Oncological Sciences

    Source: livhospital.com profile page

  12. The Effect of Adjuvant Chemotherapy on Anthropometric Measurements, Energy and Nutrient İntake in Breast Cancer Patients

    Source: livhospital.com profile page

  13. O Muhsiroglu, C Acikel, F Arpaci, N Rakicioglu

    Source: livhospital.com profile page

  14. International Journal of Health Sciences and Research 7 (7)

    Source: livhospital.com profile page

  15. Leptomeningeal Carcinomatosis in a Krukenberg Tumor Associated with Signet Ring Cell Gastric Cancer

    Source: livhospital.com profile page

  16. BB BAŞGÖZ, B Yildiz, A Aydin, G Erdem, H Aslan, K Sağlam, F Arpaci

    Source: livhospital.com profile page

  17. Turkish Journal of Oncology 31 (3)

    Source: livhospital.com profile page

  18. Development of Doxorubicin Loaded Immunoliposomes and Investigation of In Vitro Cytotoxicity on B Lymphoma Cells

    Source: livhospital.com profile page

  19. AD Dalgıç, A Tezcaner, P Elçi, M Sarper, F Arpacı, F Avcu, D Keskin

    Source: livhospital.com profile page

  20. Development of Calcitriol Doxorubicin Co loaded Liposomes

    Source: livhospital.com profile page

  21. A Necchi, R Miceli, M Bregni, K Oechsle, E Kanfer, C Massard, A Flechon, ...

    Source: livhospital.com profile page

  22. Journal of Clinical Oncology 33 (15_suppl), 4535-4535

    Source: livhospital.com profile page

  23. High-dose chemotherapy and autologous hematopoietic stem cell transplantation as adjuvant treatment in high-risk breast cancer: data from the EBMT registry 1995-2005

    Source: livhospital.com profile page

  24. M Martino, P Pedrazzoli, A Zambelli, U de Giorgi, F Arpaci, D Blaise, ...

    Source: livhospital.com profile page

  25. BONE MARROW TRANSPLANTATION 50 (1), S309-S309

    Source: livhospital.com profile page

  26. S Ozaydin, M Ozturk, T Topal, B Uysal, YG Kurt, B Kurt, G Ozgur, F Arpaci, ...

    Source: livhospital.com profile page

  27. Leukemia Research 38, S33-S33

    Source: livhospital.com profile page

  28. I Turker, S Komurcu, A Arican, F Cay Senler, O Ozyilkan, HS Coskun, ...

    Source: livhospital.com profile page

  29. Journal of Clinical Oncology 32 (15_suppl), e20503-e20503

    Source: livhospital.com profile page

  30. HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION OF HEMATOLOGICAL MALIGNANCIES IN GATA TRANSPLANT CENTER: A SINGLE-CENTER EXPERIENCE

    Source: livhospital.com profile page

  31. G Ozgur, I Eker, N Karadurmus, E Rustemov, O Babacan, S Ozaydin, ...

    Source: livhospital.com profile page

  32. BONE MARROW TRANSPLANTATION 49, S476-S476

    Source: livhospital.com profile page

  33. NAUSEA PROFILE ACCORDING TO CONDITIONING REGIMENS IN CANCER PATIENTS UNDERWENT HIGH DOSE CHEMOTHERAPY AND STEM CELL TRANSPLANTATION

    Source: livhospital.com profile page

  34. M Ozturk, S Komurcu, N Karadurmus, S Ozaydin, G Erdem, R Ogur, ...

    Source: livhospital.com profile page

  35. S Ozaydın, M Ozturk, N Karadurmus, G Erdem, F Arpacı

    Source: livhospital.com profile page

  36. Leukemia Research, S50-S51

    Source: livhospital.com profile page

  37. S Ozaydin, M Ozturk, G Ozgur, N Karadurmus, F Arpaci

    Source: livhospital.com profile page

  38. Leukemia Research, S65

    Source: livhospital.com profile page

  39. S Ozaydin, M Ozturk, N Karadurmus, G Erdem, F Arpaci

    Source: livhospital.com profile page

  40. Leukemia Research, S52

    Source: livhospital.com profile page

  41. S Ozaydin, S Ataergin, M Ozturk, N Karadurmus, G Erdem, F Arpaci

    Source: livhospital.com profile page

  42. Leukemia Research, S50

    Source: livhospital.com profile page

  43. N Karadurmus, S Ataergin, G Erdem, M Cakar, O Kuzhan, T Turker, ...

    Source: livhospital.com profile page

  44. European Journal of Internal Medicine 24, e141

    Source: livhospital.com profile page

  45. Demographic and clinical data on nonseminomatous germ cell tumours and long-term (1993-2011) results: GATA experience

    Source: livhospital.com profile page

  46. EUROPEAN JOURNAL OF CANCER 49, S653-S653

    Source: livhospital.com profile page

  47. Brentuximab vedotin (SGN-35) in Hodgkin's lymphoma patients with relapsed after autologous peripheral blood stem-cell transplantation

    Source: livhospital.com profile page

  48. G Erdem, N Karadurmus, S Ozaydin, AO Karacalioglu, C Yeginer, ...

    Source: livhospital.com profile page

  49. EUROPEAN JOURNAL OF CANCER 49, S853-S853

    Source: livhospital.com profile page

  50. M Ozturk, F Arpaci, S Ozaydin, N Karadurmus, E Ozdemir, S Ataergin, ...

    Source: livhospital.com profile page